Invention Grant
- Patent Title: Macrocyclic hepatitis C serine protease inhibitors
-
Application No.: US13439551Application Date: 2012-04-04
-
Publication No.: US08642538B2Publication Date: 2014-02-04
- Inventor: Yiyin Ku , Keith F. McDaniel , Hui-Ju Chen , Jason P. Shanley , Dale J. Kempf , David J. Grampovnik
- Applicant: Yiyin Ku , Keith F. McDaniel , Hui-Ju Chen , Jason P. Shanley , Dale J. Kempf , David J. Grampovnik
- Applicant Address: US IL North Chicago
- Assignee: AbbVie, Inc.
- Current Assignee: AbbVie, Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Edwards Wildman Palmer LLP
- Agent Jeffrey D. Hsi; Mark D. Russett
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A01N37/18
Abstract:
The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
Public/Granted literature
- US20120196792A1 MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS Public/Granted day:2012-08-02
Information query
IPC分类:
